Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.
暂无分享,去创建一个
M. Kozal | A. Tostevin | M. Gompels | A. Cozzi-Lepri | R. Marvig | Shweta Sharma | M. Bennedbaek | David Dunn | Angie N Pinto | Jens D. Lundgren | John D. Baxter